MRSA in patients with cystic fibrosis

被引：0
|
作者：
Estrada, B [1 ]
机构：
[1] Univ S Alabama, Div Infect Dis, Mobile, AL 36688 USA
来源：
INFECTIONS IN MEDICINE | 2004年 / 21卷 / 01期
关键词：
Staphylococcus aureus; cystic fibrosis;
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] MRSA-Eradication in Patients with Cystic Fibrosis
    Adams, I.
    [J]. ALLERGOLOGIE, 2013, 36 (04) : 198 - 199
  • [2] The Impact of MRSA on Lung Function in Patients with Cystic Fibrosis
    Sawicki, Gregory S.
    Rasouliyan, Lawrence
    Ren, Clement L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (08) : 734 - 735
  • [3] MRSA colonisation in patients with cystic fibrosis:: antimicrobial susceptibility pattern
    Monclús, D
    Buendía, B
    Girón, RM
    de Ayala, AP
    García-Peñuela, E
    López-Brea, M
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S95 - S96
  • [4] PERSISTENT MRSA IN CHILDREN WITH CYSTIC FIBROSIS
    Nguyen, T.
    Marcotte, J.
    Bergeron, C.
    Ovetchkine, P.
    Denis, M.
    Laberge, S.
    [J]. PEDIATRIC PULMONOLOGY, 2010, : 354 - 354
  • [5] Predominance of hospital-associated MRSA among cystic fibrosis patients in a Turkish reference cystic fibrosis centre
    Yurdakul, Pinar
    Ocal, Hamdiye Yesim
    Gulmez, Dolunay
    Yalcin, Ebru
    Dogru, Deniz
    Cinel, Guzin
    Ozcelik, Ugur
    Kiper, Nural
    Sener, Burcin
    [J]. JOURNAL OF CHEMOTHERAPY, 2012, 24 (04) : 195 - 200
  • [6] Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA
    Maria Celeste Varela
    Melanie Roch
    Agustina Taglialegna
    Scott W. Long
    Matthew Ojeda Saavedra
    Warren E. Rose
    James J. Davis
    Lucas R. Hoffman
    Rafael E. Hernandez
    Roberto R. Rosato
    Adriana E. Rosato
    [J]. Communications Biology, 3
  • [7] Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA
    Varela, Maria Celeste
    Roch, Melanie
    Taglialegna, Agustina
    Long, Scott W.
    Saavedra, Matthew Ojeda
    Rose, Warren E.
    Davis, James J.
    Hoffman, Lucas R.
    Hernandez, Rafael E.
    Rosato, Roberto R.
    Rosato, Adriana E.
    [J]. COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [8] THE DISTRIBUTION OF VANCOMYCIN MEAN INHIBITORY CONCENTRATIONS IN CYSTIC FIBROSIS PATIENTS WITH MRSA
    Allada, G.
    Briggs, E.
    Nguyen, T.
    Gold, J. A.
    [J]. PEDIATRIC PULMONOLOGY, 2010, : 354 - 355
  • [9] Predictors of eradication failure at first isolation of MRSA in cystic fibrosis patients
    Mursaloglu, Huseyin Hakan
    Akin, Can
    Yilmaz, Cansu
    Ergenekon, Pinar
    Gokdemir, Yasemin
    Eralp, Ela Erdem
    Karakoc, Fazilet
    Karahasan, Aysegul
    Karadag, Bulent
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] MRSA Characteristics In A Cystic Fibrosis Pediatric Population
    Read, L.
    McNamara, J.
    Johnson, M.
    Liu, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
12345